2024-03-28T09:08:55Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_D7FD075C9638
2024-03-23T03:03:43Z
serval:BIB_D7FD075C9638
Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.
10.1038/s41433-018-0212-2
000458009500018
30194380
Willcox
A.
author
Culliford
L.
author
Ellis
L.
author
Rogers
C.A.
author
Cree
A.
author
Chakravarthy
U.
author
Ennis
S.
author
Behar-Cohen
F.
author
Reeves
B.C.
author
Sivaprasad
S.
author
Lotery
A.
author
article
2019-02
Eye
1476-5454
0950-222X
journal
33
2
295-303
Administration, Oral
Adult
Central Serous Chorioretinopathy/diagnosis
Central Serous Chorioretinopathy/drug therapy
Central Serous Chorioretinopathy/physiopathology
Double-Blind Method
Eplerenone/therapeutic use
Female
Fluorescein Angiography
Humans
Male
Medication Adherence
Middle Aged
Mineralocorticoid Receptor Antagonists/therapeutic use
Placebos
Quality of Life
Subretinal Fluid
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity/physiology
Young Adult
eng
60_published
peer-reviewed
Publication types: Journal Article ; Multicenter Study ; Randomized Controlled Trial
Publication Status: ppublish